Jamieson Laboratories Products Recall - Defective Tamper-Evident Seals
Summary
Health Canada issued a Type III recall for Jamieson Laboratories three natural health product capsule lines due to potentially defective tamper-evident seals. Affected products include Joint pain relief capsules (NPN 80140241, lot 70794), Magnesium bisglycinate Capsules (NPN 80131651, 12 lots), and Maca capsules (NPN 80134082, 3 lots). The recall depth extends to wholesalers and retailers. No compliance deadline or penalties are specified.
What changed
Health Canada has issued a Type III health product recall (Identification RA-81822) for Jamieson Laboratories Ltd. products due to potentially defective tamper-evident seals on specific product lots. The affected products are three capsule-based natural health products: Joint pain relief capsules (lot 70794), Magnesium bisglycinate Capsules (lots including 69249, 69480A, 69650A, 70147, 70530, and others), and Maca capsules (lots 68776, 69462, 70151). The recall applies to the wholesale and retail distribution levels.
Wholesalers and retailers should verify whether they hold any affected lots and remove them from sale. Consumers who possess affected products should consult their healthcare provider before discontinuing use and contact Jamieson Laboratories directly with questions. All adverse reactions or health product safety complaints should be reported to Health Canada through the appropriate channels.
What to do next
- Verify inventory for affected lot numbers across all three product lines
- Remove affected products from shelves and alert wholesale/retail customers
- Report any adverse health effects to Health Canada
Source document (simplified)
Health product recall
Jamieson Laboratories products recall; Tamper-evident seals defective
Brand(s)
Last updated
2026-04-01
Summary
Product Joint pain relief capsule; Magnesium bisglycinate Capsules; Maca capsules Issue Health products - Packaging What to do Consult your health care professional if you have any health concerns.
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot Number |
| --- | --- | --- | --- | --- | --- |
| Jamieson Laboratories | Joint pain relief capsules | NPN 80140241 | Capsule | Partially hydrolysed chicken eggshell membrane 500.0 mg
Vitamin D 25.0 Micrograms | 70794 |
| Jamieson Laboratories | Magnesium bisglycinate Capsules | NPN 80131651 | Capsule | Magnesium 100.0 mg | 69249, 69480A, 69650A, 70147, 70530, 69480, 69650, 69804, 70149, 70527, 68744 |
| Jamieson Laboratories | Maca capsules | NPN 80134082 | Capsule | Lepidium meyenii 150.0 mg | 68776, 69462, 70151 |
Issue
Tamper-evident seals may be defective in the affected lot(s).
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Wholesalers & Retailers
Details
Original published date:
2026-04-01
Alert / recall type Health product recall Category Health products - Natural health products Companies Jamieson Laboratories Ltd.
4025 Rhodes Drive,
Windsor, Ontario N8W5B5 Canada
Published by Health Canada Audience General public Healthcare Industry Recall class Type III Identification number RA-81822
Get notified
Receive emails about new and updated recall and safety alerts.
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when Health Canada Recalls & Safety Alerts publishes new changes.